{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:42:17Z","timestamp":1794271337958,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s13760-016-0689-z","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T13:09:39Z","timestamp":1471352979000},"page":"245-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients"],"prefix":"10.1007","volume":"117","author":[{"given":"Athena","family":"Alipour-Faz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Shojaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-0877","authenticated-orcid":false,"given":"Hassan","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Ramzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbobeh","family":"Oroei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"issue":"1","key":"689_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1196\/annals.1405.004","volume":"1132","author":"JR Sonett","year":"2008","unstructured":"Sonett JR, Jaretzki A III (2008) Thymectomy for non thymomatous myasthenia gravis. Ann N Y Acad Sci 1132(1):315\u2013328","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"689_CR2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1196\/annals.1254.036","volume":"998","author":"A Vincent","year":"2003","unstructured":"Vincent A, McConville J, Farrugia ME, Bowen J, Plested P, Tang T, Evoli A, Matthews I, Sims G, Dalton P (2003) Antibodies in myasthenia gravis and related disorders. Ann N Y Acad Sci 998(1):324\u2013335","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"689_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","volume":"18","author":"A Vincent","year":"2005","unstructured":"Vincent A, Leite MI (2005) Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 18(5):519\u2013525","journal-title":"Curr Opin Neurol"},{"key":"689_CR4","doi-asserted-by":"crossref","unstructured":"Hohlfeld R, Wekerle H (2012) The immunopathogenesis of myasthenia gravis. In: Engel AG (ed) Myasthenia gravis and myasthenic disorders, vol 81. Oxford university press, p 60","DOI":"10.1093\/med\/9780199738670.003.0003"},{"issue":"2","key":"689_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37(2):141\u2013149","journal-title":"Muscle Nerve"},{"issue":"3","key":"689_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","volume":"34","author":"A McGrogan","year":"2010","unstructured":"McGrogan A, Sneddon S, De Vries CS (2010) The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 34(3):171\u2013183","journal-title":"Neuroepidemiology"},{"issue":"4","key":"689_CR7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","volume":"29","author":"JC Keesey","year":"2004","unstructured":"Keesey JC (2004) Clinical evaluation and management of myasthenia gravis. Muscle Nerve 29(4):484\u2013505","journal-title":"Muscle Nerve"},{"issue":"5","key":"689_CR8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475\u2013490","journal-title":"Lancet Neurol"},{"issue":"1","key":"689_CR9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1196\/annals.1405.038","volume":"1132","author":"L Zinman","year":"2008","unstructured":"Zinman L, Bril V (2008) IVIG treatment for myasthenia gravis. Ann N Y Acad Sci 1132(1):264\u2013270","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"689_CR10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","volume":"68","author":"L Zinman","year":"2007","unstructured":"Zinman L, Ng E, Bril V (2007) IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial. Neurology 68(11):837\u2013841","journal-title":"Neurology"},{"issue":"3","key":"689_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/CND.0b013e3181660807","volume":"9","author":"P Jensen","year":"2008","unstructured":"Jensen P, Bril V (2008) A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis. J Clin Neuromuscul Dis 9(3):352\u2013355","journal-title":"J Clin Neuromuscul Dis"},{"key":"689_CR12","doi-asserted-by":"publisher","unstructured":"Gajdos P, Chevret S, Toyka KV (2002) Plasma exchange for generalised myasthenia gravis. Cochrane Database Syst Rev (4), Wiley. doi: 10.1002\/14651858.CD002275","DOI":"10.1002\/14651858.CD002275"},{"key":"689_CR13","doi-asserted-by":"publisher","unstructured":"Gajdos P, Chevret S, Toyka K (2008) Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev (1), Wiley. doi: 10.1002\/14651858.CD002277","DOI":"10.1002\/14651858.CD002277"},{"issue":"4","key":"689_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1526-0968.2000.004004291.x","volume":"4","author":"HC Chiu","year":"2000","unstructured":"Chiu HC, Chen WH, Yeh JH (2000) The six year experience of plasmapheresis in patients with myasthenia gravis. Ther Apheresis 4(4):291\u2013295","journal-title":"Ther Apheresis"},{"issue":"7","key":"689_CR15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinte.1986.00360190143020","volume":"146","author":"EL Arsura","year":"1986","unstructured":"Arsura EL, Bick A, Brunner NG, Namba T, Grob D (1986) High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med 146(7):1365\u20131368","journal-title":"Arch Intern Med"},{"issue":"6","key":"689_CR16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","volume":"41","author":"P Gajdos","year":"1997","unstructured":"Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C (1997) Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 41(6):789\u2013796","journal-title":"Ann Neurol"},{"issue":"12","key":"689_CR17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1525-1594.2001.06717.x","volume":"25","author":"J R\u00f8nager","year":"2001","unstructured":"R\u00f8nager J, Ravnborg M, Hermansen I, Vorstrup S (2001) Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. Artif Organs 25(12):967\u2013973","journal-title":"Artif Organs"},{"issue":"12","key":"689_CR18","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1212\/WNL.40.12.1828","volume":"40","author":"DJ Lanska","year":"1990","unstructured":"Lanska DJ (1990) Indications for thymectomy in myasthenia gravis. Neurology 40(12):1828","journal-title":"Neurology"},{"issue":"2","key":"689_CR19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0003-4975(94)90993-8","volume":"57","author":"WH Frist","year":"1994","unstructured":"Frist WH, Thirumalai S, Doehring CB, Merrill WH, Stewart JR, Fenichel GM, Bender HW (1994) Thymectomy for the myasthenia gravis patient: factors influencing outcome. Ann Thorac Surg 57(2):334\u2013338","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"689_CR20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-0404.2003.00131.x","volume":"108","author":"CS Huang","year":"2003","unstructured":"Huang CS, Hsu HS, Kao KP, Huang MH, Huang BS (2003) Intravenous immunoglobulin in the preparation of thymectomy for myasthenia gravis. Acta Neurol Scand 108(2):136\u2013138","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"689_CR21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-5223(19)35177-3","volume":"96","author":"A Jaretzki 3rd","year":"1988","unstructured":"Jaretzki A 3rd, Wolff M (1988) \u201cMaximal\u201d thymectomy for myasthenia gravis. Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 96(5):711\u2013716","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"689_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000658-197610000-00008","volume":"184","author":"JM Buckingham","year":"1976","unstructured":"Buckingham JM, Howard FM Jr, Bernatz PE, Payne WS, Harrison EG Jr, O\u2019Brien PC, Weiland LH (1976) The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg 184(4):453","journal-title":"Ann Surg"},{"issue":"5","key":"689_CR23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.33588\/rn.3305.2001132","volume":"33","author":"NJ P\u00e9rez","year":"2000","unstructured":"P\u00e9rez NJ, Dominguez A, Llorens-Figueroa J, Ferra-Betancourt A, Pardo A, Quiala M, Gali Z (2000) A comparative study of intravenous immunoglobulin and plasmapheresis preoperatively in myasthenia. Rev Neurol 33(5):413\u2013416","journal-title":"Rev Neurol"},{"issue":"23","key":"689_CR24","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","volume":"76","author":"D Barth","year":"2011","unstructured":"Barth D, Nouri MN, Ng E, Nwe P, Bril V (2011) Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology 76(23):2017\u20132023","journal-title":"Neurology"},{"issue":"2","key":"689_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CND.0b013e31822c34dd","volume":"13","author":"C Heatwole","year":"2011","unstructured":"Heatwole C, Johnson N, Holloway R, Noyes K (2011) Plasma exchange vs. intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study. J Clin Neuromuscul Dis 13(2):85","journal-title":"J Clin Neuromuscul Dis"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-016-0689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-016-0689-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-016-0689-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-016-0689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:29:55Z","timestamp":1749061795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-016-0689-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s13760-016-0689-z","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]}}}